Predictive value of the international prostate symptom score for positive prostate needle biopsy in the low-intermediate prostate-specific antigen range

Urologia Internationalis

Volumn 75, Issue 3, 2005, Pages 222-226

  Kefi, Aykut ^a   Irer, Bora ^a   Ozdemir, Ismail ^a   Tuna, Burcin ^a   Goktay, Yigit ^a   Yorukoǧlu, Kutsal ^a   Esen, Adil ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Antigen, prostate specific; Biopsy, prostate; Cancer, prostate; Prostate symptom score

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY;

AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECTUM; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUMOR MARKERS, BIOLOGICAL;

EID: 26444557980     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087798     Document Type: Article

References (16)

1. Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC: Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol 1990;143:747-752.
2. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151:1283-1290.
3. Uemura H, Nakamura M, Hasumi H, Sugiura S, Fujinami K, Miyoshi Y, Yao M, Kubota Y: Effectiveness of percent free prostate specific antigen as a predictor of prostate cancer detection on repeat biopsy. Int J Urol 2004;11:494-500.
4. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM: Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 1993;270:860-864.
5. Seaman E, Whang M, Olsson CA, Katz A, Cooner WH, Benson MC: PSA density (PSAD): role in patient evaluation and management. Urol Clin North Am 1993;20:653-663.
6. Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen MT, Cockett AT, Abrahamsson PA, Lilja H: Serum prostate specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993;150:100-105.
7. Noldus J, Graefen M, Huland E, Busch C, Hammerer P, Huland H: The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer. J Urol 1998;159:2004-2008.
8. Porter CR, Kim J: Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients. Urology 2004;63:90-94.
9. Terris MK, Stamey TA: Determination of prostate volume by transrectal ultrasound. J Urol 1991;145:984-987.
10. Babaian RJ, Toi A, Kamoi K, Troncoso P, Sweet J, Evans R, Johnston D, Chen M: A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000;163:152-157.
11. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT: Measurement Committee of the AUA: the American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992;148:1549-1557.
12. Lehrer S, Stone NN, Droller MJ, Stock RG: Association between American Urologic Association (AUA) urinary symptom score and disease stage in men with localized prostate cancer. Urol Oncol 2002;7:73-76.
13. McNeal JE, Redwine EA, Freiha FS, Stamey TA: Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12:897-906.
14. Lam JS, Cheung YK, Benson MC, Goluboff ET: Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men. J Urol 2003;170:451-456.
15. Catalona WJ, Richie JP, deKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC: Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J Urol 1994;152:2031-2036.
16. Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR: Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol 1998;159:1247-1250.